[Malignant central nervous system tumors are susceptible to specific antibodies]. / Zlokachestvennye opukholi tsentral'noi nervnoi sistemy mogut byt' dostupny dlia ataki spetsificheskimi antitelami.

The binding of circulating specific IgG to glioblastoma cells from brain tumor biopsies was shown using fluorescence conjugate Protein A-FITC and Western blotting. Blood-brain barrier permeability for antitumor antibodies in vivo in glioblastoma patients is suggested.